Year archive

WAVERLEY PHARMA INC. — 2025 filings

All 15 regulatory filings released by WAVERLEY PHARMA INC. (WAVE) in 2025, sourced directly from the official regulator.

15 Filings

2025 Period

2025 filings (15)

Filing	Released	Lang
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-05-22	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-05-22	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-05-22	English
Interim MD&A - English.pdf Management Reports	2025-05-22	English
Interim financial statements/report – English.pdf Interim / Quarterly Report Q1 2025	2025-05-22	English
Form of proxy - English.pdf Proxy Solicitation & Information Statement	2025-05-22	English
Management information circular - English.pdf Proxy Solicitation & Information Statement	2025-05-22	English
Notice of meeting - English.pdf Proxy Solicitation & Information Statement	2025-05-22	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2025-04-30	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2025-04-30	English
Annual MD&A - English.pdf Management Reports	2025-04-30	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-04-30	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-04-30	English
Audited annual financial statements – English.pdf Audit Report / Information FY 2024	2025-04-29	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2025-04-10	English